Literature DB >> 30215569

From vaccines to global health to vaccines.

Marie-Paule Kieny1.   

Abstract

Year:  2018        PMID： 30215569      PMCID： PMC6314424          DOI： 10.1080/21645515.2018.1507375

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  7 in total

Review 1.  WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.

Authors:  Martin Friede; Laszlo Palkonyay; Claudia Alfonso; Yuri Pervikov; Guido Torelli; David Wood; Marie Paule Kieny
Journal:  Vaccine       Date:  2011-07-01       Impact factor: 3.641

2.  First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus.

Authors:  P P Pastoret; B Brochier; B Languet; I Thomas; A Paquot; B Bauduin; M P Kieny; J P Lecocq; J De Bruyn; F Costy
Journal:  Vet Rec       Date:  1988-11-05       Impact factor: 2.695

3.  Improved antigenicity of the HIV env protein by cleavage site removal.

Authors:  M P Kieny; R Lathe; Y Rivière; K Dott; D Schmitt; M Girard; L Montagnier; J Lecocq
Journal:  Protein Eng       Date:  1988-09

4.  Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.

Authors:  Peter B Gilbert; James O Berger; Donald Stablein; Stephen Becker; Max Essex; Scott M Hammer; Jerome H Kim; Victor G Degruttola
Journal:  J Infect Dis       Date:  2011-04-01       Impact factor: 5.226

5.  Expression of rabies virus glycoprotein from a recombinant vaccinia virus.

Authors:  M P Kieny; R Lathe; R Drillien; D Spehner; S Skory; D Schmitt; T Wiktor; H Koprowski; J P Lecocq
Journal:  Nature       Date:  1984 Nov 8-14       Impact factor: 49.962

6.  Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Authors:  Ana Maria Henao-Restrepo; Anton Camacho; Ira M Longini; Conall H Watson; W John Edmunds; Matthias Egger; Miles W Carroll; Natalie E Dean; Ibrahima Diatta; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Pierre-Stéphane Gsell; Stefanie Hossmann; Sara Viksmoen Watle; Mandy Kader Kondé; Sakoba Kéïta; Souleymane Kone; Eewa Kuisma; Myron M Levine; Sema Mandal; Thomas Mauget; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; John-Arne Røttingen; Marie-Paule Kieny
Journal:  Lancet       Date:  2016-12-23       Impact factor: 79.321

7.  Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.

Authors:  F Marc LaForce; Mamoudou Djingarey; Simonetta Viviani; Marie-Pierre Preziosi
Journal:  Hum Vaccin Immunother       Date:  2017-11-08       Impact factor: 3.452
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.